Expedeon AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Expedeon AG with three other
companies in this sector in Germany:
sales of 4.20 million Euro [US$4.73 million]
(10.30 million Euro [US$11.61 million]
of which 47%
was Immunotherapies), and
Heidelberg Pharma Ag
(1.90 million Euro [US$2.14 million]
Sales increased substantially in 2017:
Expedeon AG reported sales of 7.80 million Euro (US$8.79 million)
December of 2017.
increase of 335.8%
versus 2016, when the company's sales were 1.79 million Euro.
This was the third consecutive year of growth at Expedeon AG.